|
What is the clinical effectiveness and cost-effectiveness of using drugs in treating obese patients in primary care? A systematic review |
Ara R, Blake L, Gray L, Hernandez M, Crowther M, Dunkley A, Warren F, Jackson R, Rees A, Stevenson M, Abrams K, Cooper N, Davies M, Khunti K, Sutton A |
|
|
Record Status This is an economic evaluation that meets the criteria for inclusion on NHS EED. Bibliographic details Ara R, Blake L, Gray L, Hernandez M, Crowther M, Dunkley A, Warren F, Jackson R, Rees A, Stevenson M, Abrams K, Cooper N, Davies M, Khunti K, Sutton A. What is the clinical effectiveness and cost-effectiveness of using drugs in treating obese patients in primary care? A systematic review. Health Technology Assessment 2012; 16(5): 1-202 Indexing Status Subject indexing assigned by NLM MeSH Anti-Obesity Agents /economics /therapeutic use; Cost-Benefit Analysis; Cyclobutanes /economics /therapeutic use; Drug Costs /statistics & Exercise; Female; Humans; Lactones /economics /therapeutic use; Male; Middle Aged; Obesity /drug therapy; Piperidines /economics /therapeutic use; Primary Health Care /economics /methods; Pyrazoles /economics /therapeutic use; Risk Reduction Behavior; Treatment Outcome; numerical data AccessionNumber 22012008907 Date bibliographic record published 26/04/2012 |
|
|
|